• FDA approves Aristada Initio for schizophrenia

    18 days ago - By Healio

    David P. Walling
    The FDA has approved Aristada Initio for the initiation of Aristada, a long-acting injectable atypical antipsychotic medication, to treat adults with schizophrenia, according to a press release.
    In combination with a single 30-mg dose of oral aripiprazole, Aristada Initio enables physicians to fully dose up to 2 months of Aristada on day one of treatment with an alternative regimen, the release said.
    According to the release, Aristada Initio is anticipated to be available in mid-July.
    "The approval of
    Read more ...

     

  • FDA Clears 'Day One' Aristada Regimen for Treating Schizophrenia

    18 days ago - By Medscape

    The FDA has cleared an extended-release injectable version of aripiprazole lauroxil, making it the 'first and only long-acting atypical antipsychotic that can be initiated on day one,' say researchers.
    FDA Approvals
    Read more ...

     

  • FDA OK's 1-Day Initiation for Long-Acting Injectable Schizophrenia Tx

    18 days ago - By MedPageToday

    May replace previous 21-day initiation regimen onto aripiprazole lauroxil
    Read more ...